| Trial ID: | L0549 |
| Source ID: | IRCT201701162709N39
|
| Associated Drug: |
Sumac
|
| Title: |
The effect of supplementation with sumac powder on liver enzymes (Alanine aminotransferase and Aspartate aminotransferase ), lipid profiles(Triglyceride,Total cholestrol,High density lipoprotein,Low density lipoprotein)? leptin and liver steatosis in pat
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Control group: daily 2 g dextrin as 4 capsules of 500 mg. Intervention 2: Intervention group: daily 2 g sumac as 4 capsules of 500 mg.;Treatment - Drugs;Treatment - Drugs;Control group: daily 2 g dextrin as 4 capsules of 500 mg;Interventio
|
| Outcome Measures: |
Alanine aminotransferase. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Spectrophotometry.;Aspartate aminotransferase. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Spectrophotometry.;Hepatic steatosis. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Using the scanning fiber 502.Total cholestrol. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Spectrophotometry.;Triglycerides. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Spectrophotometry.;Low density lipoprotein. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Spectrophotometry.;High density lipoprotein. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Spectrophotometry.;Leptin. Timepoint: Before the start of treatment and 12 weeks after intervention. Method of measurement: Elisa.
|
| Sponsor/Collaborators: |
Vice Chancellor for Research of Iran university Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years60 years
|
| Phases: |
Not applicable
|
| Enrollment: |
80
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive.
|
| Start Date: |
06/05/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/2550
|
